Interfacing Chemical Biology and Drug Discovery
Conferences > Archives > RICT 2021

Programme

Indicated times are in CEST timezone.


Wednesday July 7, 2021
RICT Opening
09:45Opening Ceremony
Prof. Rebecca DEPREZ-POULAIN (UNIVERSITY OF LILLE / INSTITUT PASTEUR OF LILLE, Lille, France)
Prof. Sebastien PAPOT (SCT & UNIVERSITY OF POITIERS, Poitiers, France)
Chemical Biology and Target validation
Session Chair
Dr Boris VAUZEILLES
(INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES, Gif-sur-Yvette, France)
10:00Expanding the Genetic Code - Chemistry in Living Systems (PL01)
Prof. Kathrin LANG
(ETH ZURICH, Zurich, Switzerland)
10:30Ligand-Directed Labeling of Endogenous Proteins in Live Cells (PL02)
Prof. Itaru HAMACHI
(KYOTO UNIVERSITY, Kyoto, Japan)
11:00Networking & Exhibition break
Session Chair
Dr Frédéric SCHMIDT
(INSTITUT CURIE, Paris, France)
11:30Bioorthogonal Protein Activation in Living Systems (PL03)
Prof. Peng CHEN
(PEKING UNIVERSITY, Beijing, China)
12:00Chemical Biology Tools for Enlightening Therapies (IL01)
Prof. Olalla VÁZQUEZ
(PHILIPPS-UNIVERSITÄT MARBURG, Marburg, Germany)
12:20End of morning session
Poster Session 1
Exhibition
Networking
New Modalities in Drug Discovery
Session Chair
Prof. Mélanie ETHEVE-QUELQUEJEU
(UNIVERSITÉ DE PARIS, Paris, France)
15:00Chemical Targeting of DNA and Histone Methylationto Reprogram Cells in Human Diseases: Challenges and Future Perspectives (PL04)
Dr Paola B. ARIMONDO
(INSTITUT PASTEUR - CNRS, Paris, France)
15:30The Second Dimension of the Genetic Code (PL05)
Prof. Thomas CARELL
(LUDWIG-MAXIMILIANS-UNIVERSITY, München, Germany)
16:00Networking & Exhibition break
Session Chair
Dr Maria DUCA
(UNIVERSITY OF CÔTE D'AZUR, Nice, France)
16:30From Simple to Complex in Natural Product Chemistry: Bio-Inspired Strategies to Escape “Flatland” (PL06)
Prof. Erwan POUPON
(PARIS-SACLAY UNIVERSITY, Châtenay-Malabry, France)
17:00Taming Random Conjugation: a General Approach for Equimolar Linking of Proteins and Payloads (IL02)
Dr Sergii KOLODYCH
(SYNDIVIA, Strasbourg, France)
17:20End of afternoon session
Thursday July 8, 2021
Case Studies and Disclosures
Session Chair
Dr Pascal GEORGE
(SCT & SCIENTIFIC EXPERT & ADVISER IN DRUG DESIGN AND DEVELOPMENT, Longvilliers, France)
10:00Steroid Sulfatase Inhibition: from Concept to Clinical and Beyond (PL07)
Prof. Barry POTTER
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
10:30Recent Advances In Breast Cancer Treatment: Discovery of Amcenestrant (SAR439859), An Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) to Treat ER+ Breast Cancers (PL08)
Dr Youssef EL AHMAD
(SANOFI, Vitry Sur Seine, France)
11:00Networking & Exhibition break
Session Chair
Dr Olivier MIRGUET
(EVOTEC, Toulouse, France)
11:30Daridorexant - a Dual Orexin Receptor Antagonist (PL09)
Dr Christoph BOSS
(IDORSIA PHARMACEUTICALS LTD, Allschwil, Switzerland)
12:00Anti-Virulence Agent to Treat S. Aureus Infections (IL03)
Dr Alessia MICHELOTTI
(BIOVERSYS AG, Lille, France)
12:20End of morning session
Poster Session 2
Exhibition
Networking
New Tools for Therapeutic Innovation
Session Chair
Prof. Sébastien LECOMMANDOUX
(LCPO, ENSCBP-BORDEAUX INP, Pessac, France)
15:00Multi-Target-Directed Ligands to Combat Neurodegenerative Diseases: All-In-One and One-For-All (PL10)
Prof. Maria Laura BOLOGNESI
(UNIVERSITY OF BOLOGNA, Bologna, Italy)
15:30Converting Drug Delivery Technologies into Drugs in Unmet Medical Needs (PL11)
Prof. Jean-Christophe LEROUX
(ETH ZÜRICH, Zürich, Switzerland)
16:00Networking & Exhibition break
Prize Ceremony - Paul Ehrlich Prize
16:30Paul Ehrlich Prize Ceremony
Dr Susana CONDE CEIDE (JANSSEN, Toledo, Spain)
Dr Dominique LESUISSE (SCT & SANOFI, Chilly-Mazarin, France)
16:40Paul Ehrlich Award Lecture - 30 Years of Molecular Glues: Controlling Cell Circuitry in Biology and Medicine (PL12)
Prof. Stuart SCHREIBER
(HARVARD UNIVERSITY, Cambridge, United States)
17:25End of afternoon session
Friday July 9, 2021
Drugging the Undruggable
Session Chair
Dr Gilles GUICHARD
(UNIVERSITY OF BORDEAUX, Pessac, France)
10:00Targeting Protein-Protein Interactions in Receptor Complexes (PL13)
Prof. Kristian STROMGAARD
(UNIVERSITY OF COPENHAGEN, Copenhagen, Denmark)
10:30Selecting Targets to Harness the Therapeutic Opportunities Afforded by PROTAC-mediated Protein Degradation (PL14)
Dr John HARLING
(GLAXOSMITHKLINE, Stevenage, United Kingdom)
11:00Networking & Exhibition break
Session Chair
Prof. Dominique BONNET
(CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France)
11:30Proteomimetics as Inhibitors of Transcription Factor Complexes (PL15)
Prof. Tom GROSSMANN
(VU UNIVERSITY AMSTERDAM, Amsterdam, The Netherlands)
12:00Drugging KRAS with Medchem 2.0 (PL16)
Dr Darryl MCCONNELL
(BOEHRINGER INGELHEIM RCV, Vienna, Austria)
12:30End of morning session
Poster Session 3
Exhibition
Networking
Success Stories
Session Chair
Prof. Philippe BARTHELEMY
(UNIVERSITY OF BORDEAUX, INSERM, Bordeaux, France)
15:00Identification of the Potent, Highly Selective and Orally Bioavailable ATR Inhibitor BAY 1895344 (PL17)
Dr Franz VON NUSSBAUM
(NUVISAN ICB GMBH, Berlin, Germany)
15:30Biomimetic Chemistry of Human RNAi Therapeutics (PL18)
Dr Muthiah MANOHARAN
(ALNYLAM PHARMACEUTICALS, Cambridge, United States)
16:00Networking & Exhibition break
Prize Ceremony - Pierre Fabre Award Lecture
16:30Pierre Fabre Award Ceremony
Prof. Sebastien PAPOT
(SCT & UNIVERSITY OF POITIERS, Poitiers, France)
16:40Pierre Fabre Award Lecture - Metal Complexes in Medicinal Chemistry (PL19)
Dr Gilles GASSER
(CHIMIE PARISTECH, PSL UNIVERSITY, Paris, France)
17:25Closing Remarks
Prof. Rebecca DEPREZ-POULAIN
(UNIVERSITY OF LILLE / INSTITUT PASTEUR OF LILLE, Lille, France)
17:30End of RICT 2021

Copyright 2022 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys